Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Br J Dermatol. 2020 Dec 14;184(6):1161–1169. doi: 10.1111/bjd.19503

Figure 1. AlloHCT establishes immune tolerance for donor epidermal graft.

Figure 1.

With alloHCT, the RDEB patient immune system transitions to that of the unaffected donor. This establishes immune tolerance allowing for subsequent skin grafts from the same donor to heal chronic wounds of the patient with RDEB.